Research note · 16 October 2026
Albertsons Companies ACI
LONG price $13.09 · base case $33.18 · expected +102% over 540 days
The call
Albertsons is deeply undervalued at $13.09, as the market is pricing in a permanent margin collapse or severe credit stress driven by highly distorted fiscal 2026 earnings. The reported operating margin of 0.65% and net income decline of 77.3% are suppressed by a $773.8 million pre-tax opioid settlement, $153.7 million in business transformation costs, and $84.1 million in merger-related expenses. Despite the earnings trough, the underlying business continues to generate robust operating cash flow of $2,366.7 million and a normalized free cash flow of roughly $1,062 million.
Why the opportunity exists, in the desk's view: a transient setback.
What decides the case
- Operating margin trajectory post-transformation
- Debt refinancing and liquidity
- Consumer demand resilience
What breaks the case
| Shock to the base case | Value per share | vs price |
|---|---|---|
| Base case as planned | $33.18 | 153% |
| Starting cash flow 10% higher | $36.59 | 180% |
| Growth 5 points higher every year | $40.99 | 213% |
| Discount rate 100bp higher | $29.08 | 122% |
| Starting cash flow 10% lower | $29.77 | 127% |
| Growth 5 points lower every year | $26.64 | 104% |
| Cost of debt 200bp higher | $32.42 | 148% |
The base case equals the price at a 19.8% discount rate, or if every year's growth were -20.0% points different. Thresholds, not forecasts.
Exposures
- Interest rates, negative for the equity
Model-authored research with an editorial gate; every figure traces to the filing or a stated assumption and every calculation was reproduced before publication. Not investment advice. Do not redistribute.